Abstract

BackgroundDrugs achieve pharmacological functions by acting on target proteins. Identifying interactions between drugs and target proteins is an essential task in old drug repositioning and new drug discovery. To recommend new drug candidates and reposition existing drugs, computational approaches are commonly adopted. Compared with the wet-lab experiments, the computational approaches have lower cost for drug discovery and provides effective guidance in the subsequent experimental verification. How to integrate different types of biological data and handle the sparsity of drug-target interaction data are still great challenges.ResultsIn this paper, we propose a novel drug-target interactions (DTIs) prediction method incorporating marginalized denoising model on heterogeneous networks with association index kernel matrix and latent global association. The experimental results on benchmark datasets and new compiled datasets indicate that compared to other existing methods, our method achieves higher scores of AUC (area under curve of receiver operating characteristic) and larger values of AUPR (area under precision-recall curve).ConclusionsThe performance improvement in our method depends on the association index kernel matrix and the latent global association. The association index kernel matrix calculates the sharing relationship between drugs and targets. The latent global associations address the false positive issue caused by network link sparsity. Our method can provide a useful approach to recommend new drug candidates and reposition existing drugs.

Highlights

  • Drugs achieve pharmacological functions by acting on target proteins

  • We employed the area under curve of receiver operating characteristic (AUC) and area under precision-recall curve (AUPR) as the evaluation metrics

  • To valid our prediction method in drug reposition, in completely new drug discovery, and in completely new targets discovery respectively, we conducted the cross-validation under the following three settings: (1) CVP: Validating for drug reposition. 90% of the drug-target interaction pairs in drug-target interaction network Y were randomly selected as training data, and the left 10% of the drugtarget interaction pairs were selected as testing data

Read more

Summary

Introduction

Identifying interactions between drugs and target proteins is an essential task in old drug repositioning and new drug discovery. Identifying drug-target interactions (DTIs) is a critical work in drug discovery and drug repositioning. Different computational methods for predicting potential DTIs were proposed in the past decade [1,2,3,4,5]. The DTI prediction problem was treated as a binary classification problem Some classical classifiers such as support vector machines (SVM) and regularized least squares (RLS) were used to predict drugtarget interactions. A supervised bipartite local model (BLM) using SVM classifier was proposed to predict drug and target sets respectively [7]. The methods mentioned above focus on existing drug-target interaction pairs and mainly deal with the old drug reposition problem

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call